These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

244 related items for PubMed ID: 16634988

  • 21. Blood pressure changes associated with sibutramine and weight management - an analysis from the 6-week lead-in period of the sibutramine cardiovascular outcomes trial (SCOUT).
    Sharma AM, Caterson ID, Coutinho W, Finer N, Van Gaal L, Maggioni AP, Torp-Pedersen C, Bacher HP, Shepherd GM, James WP, SCOUT Investigators.
    Diabetes Obes Metab; 2009 Mar; 11(3):239-50. PubMed ID: 18671798
    [Abstract] [Full Text] [Related]

  • 22. Efficacy of sibutramine for the treatment of binge eating disorder: a randomized multicenter placebo-controlled double-blind study.
    Wilfley DE, Crow SJ, Hudson JI, Mitchell JE, Berkowitz RI, Blakesley V, Walsh BT, Sibutramine Binge Eating Disorder Research Group.
    Am J Psychiatry; 2008 Jan; 165(1):51-8. PubMed ID: 18056225
    [Abstract] [Full Text] [Related]

  • 23. Cardiovascular effects of sibutramine in the treatment of obese adolescents: results of a randomized, double-blind, placebo-controlled study.
    Daniels SR, Long B, Crow S, Styne D, Sothern M, Vargas-Rodriguez I, Harris L, Walch J, Jasinsky O, Cwik K, Hewkin A, Blakesley V, Sibutramine Adolescent Study Group.
    Pediatrics; 2007 Jul; 120(1):e147-57. PubMed ID: 17576783
    [Abstract] [Full Text] [Related]

  • 24. Effect of sibutramine on weight loss and blood pressure: a meta-analysis of controlled trials.
    Kim SH, Lee YM, Jee SH, Nam CM.
    Obes Res; 2003 Sep; 11(9):1116-23. PubMed ID: 12972682
    [Abstract] [Full Text] [Related]

  • 25. Use of sibutramine to assist obese women with weight loss can be successful in dietitian-led clinics: another tool in the dietitian's toolbox.
    Barratt R, Frost G, O'Boyle A, Millward J, Truby H.
    J Hum Nutr Diet; 2008 Jun; 21(3):248-55. PubMed ID: 18477180
    [Abstract] [Full Text] [Related]

  • 26. Weight loss and body fat reduction under sibutramine therapy in obesity with the C825T polymorphism in the GNB3 gene.
    Hsiao DJ, Wu LS, Huang SY, Lin E.
    Pharmacogenet Genomics; 2009 Sep; 19(9):730-3. PubMed ID: 19687782
    [Abstract] [Full Text] [Related]

  • 27. Efficacy of cognitive behavioral therapy and fluoxetine for the treatment of binge eating disorder: a randomized double-blind placebo-controlled comparison.
    Grilo CM, Masheb RM, Wilson GT.
    Biol Psychiatry; 2005 Feb 01; 57(3):301-9. PubMed ID: 15691532
    [Abstract] [Full Text] [Related]

  • 28. Effect of orlistat in obese patients with binge eating disorder.
    Golay A, Laurent-Jaccard A, Habicht F, Gachoud JP, Chabloz M, Kammer A, Schutz Y.
    Obes Res; 2005 Oct 01; 13(10):1701-8. PubMed ID: 16286517
    [Abstract] [Full Text] [Related]

  • 29. Acute effect of weight loss on levels of total bilirubin in obese, cardiovascular high-risk patients: an analysis from the lead-in period of the Sibutramine Cardiovascular Outcome trial.
    Andersson C, Weeke P, Fosbøl EL, Brendorp B, Køber L, Coutinho W, Sharma AM, Van Gaal L, Finer N, James WP, Caterson ID, Rode RA, Torp-Pedersen C, SCOUT Executive Steering Committee, SCOUT investigators.
    Metabolism; 2009 Aug 01; 58(8):1109-15. PubMed ID: 19454355
    [Abstract] [Full Text] [Related]

  • 30. Treatment of binge eating disorder in racially and ethnically diverse obese patients in primary care: randomized placebo-controlled clinical trial of self-help and medication.
    Grilo CM, Masheb RM, White MA, Gueorguieva R, Barnes RD, Walsh BT, McKenzie KC, Genao I, Garcia R.
    Behav Res Ther; 2014 Jul 01; 58():1-9. PubMed ID: 24857821
    [Abstract] [Full Text] [Related]

  • 31. Use of sibutramine, an inhibitor of the reuptake of serotonin and noradrenaline, in the treatment of binge eating disorder: a placebo-controlled study.
    Milano W, Petrella C, Casella A, Capasso A, Carrino S, Milano L.
    Adv Ther; 2005 Jul 01; 22(1):25-31. PubMed ID: 15943219
    [Abstract] [Full Text] [Related]

  • 32. Short-term effects of sibutramine (Reductil) on appetite and eating behaviour and the long-term therapeutic outcome.
    Barkeling B, Elfhag K, Rooth P, Rössner S.
    Int J Obes Relat Metab Disord; 2003 Jun 01; 27(6):693-700. PubMed ID: 12833113
    [Abstract] [Full Text] [Related]

  • 33. Treatment outcome in people with subthreshold compared with full-syndrome binge eating disorder.
    Friederich HC, Schild S, Wild B, de Zwaan M, Quenter A, Herzog W, Zipfel S.
    Obesity (Silver Spring); 2007 Feb 01; 15(2):283-7. PubMed ID: 17299100
    [Abstract] [Full Text] [Related]

  • 34. Assessment of clinical and economic benefits of weight management with sibutramine in general practice in Germany.
    Brennan A, Ara R, Sterz R, Matiba B, Bergemann R.
    Eur J Health Econ; 2006 Dec 01; 7(4):276-84. PubMed ID: 17063345
    [Abstract] [Full Text] [Related]

  • 35. The Long-term Outcomes of Sibutramine Effectiveness on Weight (LOSE Weight) study: evaluating the role of drug therapy within a weight management program in a group-model health maintenance organization.
    Porter JA, Raebel MA, Conner DA, Lanty FA, Vogel EA, Gay EC, Merenich JA.
    Am J Manag Care; 2004 Jun 01; 10(6):369-76. PubMed ID: 15209480
    [Abstract] [Full Text] [Related]

  • 36. Effects of sibutramine and orlistat on mood in obese and overweight subjects: a randomised study.
    Kiortsis DN, Tsouli S, Filippatos TD, Konitsiotis S, Elisaf MS.
    Nutr Metab Cardiovasc Dis; 2008 Mar 01; 18(3):207-10. PubMed ID: 17570651
    [Abstract] [Full Text] [Related]

  • 37. The effect of sibutramine-assisted weight loss in men with obstructive sleep apnoea.
    Yee BJ, Phillips CL, Banerjee D, Caterson I, Hedner JA, Grunstein RR.
    Int J Obes (Lond); 2007 Jan 01; 31(1):161-8. PubMed ID: 16652122
    [Abstract] [Full Text] [Related]

  • 38. [A randomized, double-blind, placebo-controlled, multicenter study on sibutramine in over-weighted and obese subjects].
    Zhao Y, Wang X, Yan Z.
    Zhonghua Yu Fang Yi Xue Za Zhi; 2001 Sep 01; 35(5):329-32. PubMed ID: 11769634
    [Abstract] [Full Text] [Related]

  • 39. Combined dietary and pharmacological weight management in obese hypopituitary patients.
    Mersebach H, Klose M, Svendsen OL, Astrup A, Feldt-Rasmussen U.
    Obes Res; 2004 Nov 01; 12(11):1835-43. PubMed ID: 15601980
    [Abstract] [Full Text] [Related]

  • 40. A randomized comparison of cognitive behavioral therapy and behavioral weight loss treatment for overweight individuals with binge eating disorder.
    Munsch S, Biedert E, Meyer A, Michael T, Schlup B, Tuch A, Margraf J.
    Int J Eat Disord; 2007 Mar 01; 40(2):102-13. PubMed ID: 17089420
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.